Hot Pursuit     25-Oct-23
Biocon Ltd eases for fifth straight session
Biocon Ltd is quoting at Rs 225.5, down 0.33% on the day as on 13:19 IST on the NSE. The stock tumbled 18.37% in last one year as compared to a 7.84% rally in NIFTY and a 11.81% spurt in the Nifty Metal index.

Biocon Ltd is down for a fifth straight session today. The stock is quoting at Rs 225.5, down 0.33% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.8% on the day, quoting at 19127.55. The Sensex is at 64031.94, down 0.84%.Biocon Ltd has lost around 13.82% in last one month.Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has eased around 1.28% in last one month and is currently quoting at 14911.65, down 0.81% on the day. The volume in the stock stood at 23.27 lakh shares today, compared to the daily average of 30.66 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 225.6, down 0.13% on the day. Biocon Ltd tumbled 18.37% in last one year as compared to a 7.84% rally in NIFTY and a 11.81% spurt in the Nifty Metal index.

The PE of the stock is 253.48 based on TTM earnings ending June 23.

Previous News
  Stock Alert: TCS, Power Grid Corporation, NMDC, Biocon, Firstsource Solutions
 ( Market Commentary - Stock Alert 07-Mar-25   08:31 )
  Biocon surges on U.S. deal for Eylea copycat drug
 ( Hot Pursuit - 15-Apr-25   09:58 )
  Biocon Biologics completes final remittance under acquisition agreement with Viatris
 ( Corporate News - 30-Dec-24   10:10 )
  Biocon Q1 PAT soars YoY to Rs 660 cr in FY25
 ( Hot Pursuit - 09-Aug-24   12:19 )
  Biocon
 ( Results - Analysis 13-Nov-23   12:15 )
  Biocon Ltd down for fifth straight session
 ( Hot Pursuit - 13-Dec-24   13:35 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 20-Feb-25   13:35 )
  Sensex spurts 714 pts; auto shares in demand
 ( Market Commentary - Mid-Session 09-Aug-24   10:32 )
  Biocon receives reaffirmation in credit rating for bank facilities
 ( Corporate News - 30-Nov-23   15:49 )
  Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India
 ( Corporate News - 14-Dec-22   19:23 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top